跳至主要内容
临床试验/JPRN-UMIN000020865
JPRN-UMIN000020865招募中4 期

Comparison of postoperative administration between dienogest and ultra low dose estrogen and progesterone tablet for suppressing recurrence of ovarian endometriomas: A randomized study - Comparison of postoperative administration between dienogest and ultra low dose estrogen and progesterone tablet for suppressing recurrence of ovarian endometriomas: A randomized study

Osaka University Hospital0 个研究点目标入组 120 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 50years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • (a) undiagnosed genital bleeding (b) pregnant, probably pregnant or lactating (c) allergic to ingredient of dinagest tablets or LUNABELL tablets ULD (d) patients who want to become pregnant (e) estrogen dependent malignant tumor (e.g. breast cancer, endometrial cancer), cervical cancer or suspected to have those diseases (f) thrombophlebitis, pulmonary embolism, cerebrovascular accident and coronary artery disease, or past history of those diseases (g) more than 35 years old and smoke more than 15 cigarettes (h) migraine with aura (e.g. fortification spectrum etc.) (i) valvular disease with pulmonary; hypertension or atrial fibrillation valvular disease with past history of subacute infectious endocarditis (j) diabetes with vascular disease (diabetic nephropathy, diabetic retinopathy etc.) (k) primary cause of thrombosis (l) antiphospholipid antibody syndrome (m) within 4 weeks before surgery, within 2 weeks after surgery, within 4 weeks after delivery, or long-term bed rest (n) severe liver damage (o) liver tumor (p) lipid metabolism abnormality (q) hypertension (except mild hypertension) (r) otosclerosis (s) past history of jaundice, persistent pruritus or herpes during pregnancy (t) probably in the middle of bone growth (u) patients who are judged ineligible by doctor in charge for other reasons

研究者

相似试验

Comparison of postoperative administration between... | 临床试验